These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18292496)

  • 21. Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients.
    López-Alvarez MR; Gómez-Mateo J; Ruiz-Merino G; Campillo JA; Miras M; García-Alonso AM; Sánchez-Bueno F; Parrilla P; Alvarez-López MR; Minguela A
    Transpl Immunol; 2006 Dec; 17(1):51-4. PubMed ID: 17157216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets.
    Estefanía E; Flores R; Gómez-Lozano N; Aguilar H; López-Botet M; Vilches C
    J Immunol; 2007 Apr; 178(7):4402-10. PubMed ID: 17371997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
    Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
    Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells.
    Basu D; Liu Y; Wu A; Yarlagadda S; Gorelik GJ; Kaplan MJ; Hewagama A; Hinderer RC; Strickland FM; Richardson BC
    J Immunol; 2009 Sep; 183(5):3481-7. PubMed ID: 19675166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage.
    Zhou XY; Yashiro-Ohtani Y; Toyo-Oka K; Park CS; Tai XG; Hamaoka T; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1260-8. PubMed ID: 10640739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacity.
    Arlettaz L; Degermann S; De Rham C; Roosnek E; Huard B
    Eur J Immunol; 2004 Dec; 34(12):3413-22. PubMed ID: 15549734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).
    Saulquin X; Gastinel LN; Vivier E
    J Exp Med; 2003 Apr; 197(7):933-8. PubMed ID: 12668644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.
    Sáez-Borderías A; Gumá M; Angulo A; Bellosillo B; Pende D; López-Botet M
    Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of killer cell inhibitor receptors on immunocompetent cells with relation to graft-versus-host disease after hematopoietic stem cell transplantation.
    Duan LN; Chen C; Huang SL; Fang JP; Wei J; Bao R; Li Y; Han HX; Li SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):625-32. PubMed ID: 14706148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
    Anfossi N; Doisne JM; Peyrat MA; Ugolini S; Bonnaud O; Bossy D; Pitard V; Merville P; Moreau JF; Delfraissy JF; Dechanet-Merville J; Bonneville M; Venet A; Vivier E
    J Immunol; 2004 Dec; 173(12):7223-9. PubMed ID: 15585844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
    Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of NK cell receptors on decidual T cells in human pregnancy.
    Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
    J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
    Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
    J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
    Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
    J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.
    Djaoud Z; David G; Bressollette C; Willem C; Rettman P; Gagne K; Legrand N; Mehlal S; Cesbron A; Imbert-Marcille BM; Retière C
    J Immunol; 2013 Sep; 191(5):2708-16. PubMed ID: 23918974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.